home / stock / alny / alny news

ALNY News and Press, Alnylam Pharmaceuticals Inc. From 10/08/23

Stock Information
Company Name: Alnylam Pharmaceuticals Inc.
Stock Symbol: ALNY
Market: NASDAQ
Website: alnylam.com
Menu
ALNY ALNY Quote ALNY Short ALNY News ALNY Articles ALNY Message Board
Get ALNY Alerts

News, Short Squeeze, Breakout and More Instantly...
ALNY - 2 Growth Stocks That Could Rocket Higher Before the End of 2023

2023-10-08 06:29:00 ET Growth-oriented investors looking for stocks that can heat up their portfolios before the end of 2023 want to turn their attention to the healthcare sector. Upcoming binary events could soon send these two biotech stocks rocketing higher. The U.S. Food and Drug Ad...
ALNY - Alnylam to Present Additional Data for Patisiran in Patients With the Cardiomyopathy of ATTR Amyloidosis, Including 24-Month Results From the APOLLO-B Phase 3 Study, at the Heart Failure Society of America Annual Scientific Meeting 2023

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the Company will present new results for patisiran, an investigational RNAi therapeutic in development for the treatment of the cardiomyopathy of transthyretin-mediated (ATTR) amyloidosis, ...

ALNY - Regeneron says Q3 results to be impacted by $100M IPR&D expense

2023-10-05 16:53:53 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals: Game-Changing Discoveries In Healthcare Regeneron and Intellia expand gene editing partnership Regeneron nabs FDA priority review for lymphoma therapy For further details see:...

ALNY - Catalyst Watch: Tesla deliveries, Google event, Kellogg spinoff, Amgen drama and Ether ETFs

2023-09-29 15:00:29 ET More on the markets Historical Evidence Between Real Yields Suggests Further Slump For SPY Interest Rates Won't Be Higher For Longer: SPY Implications Rate environment today 'rhymes with 2008' - J.P. Morgan's Kolanovic Stocks in midst o...
ALNY - Ionis, AbbVie, Alnylam draw bullish views at Raymond James

2023-09-29 13:05:39 ET More on AbbVie, Alnylam, etc. AbbVie: Company Vs. Stock, A Gentle Facelift Would Be Nice (Technical Analysis) AbbVie Vs. AstraZeneca: Battle Of The Pharmaceutical Behemoths AbbVie Inc. (ABBV) Morgan Stanley 21st Annual Global Healthcare Brokers...

ALNY - Citi says concerns over FDA approval of Alnylam drug are "overdone"

2023-09-15 14:04:22 ET More on Alnylam Pharmaceuticals Seeking Alpha’s Quant Rating on Alnylam Pharmaceuticals Historical earnings data for Alnylam Pharmaceuticals Financial information for Alnylam Pharmaceuticals Alnylam Continues To Deliver, But An U...

ALNY - Alnylam stock falls after FDA panel questions drug's effectiveness

2023-09-14 11:20:00 ET More on Alnylam Pharmaceuticals Seeking Alpha’s Quant Rating on Alnylam Pharmaceuticals Historical earnings data for Alnylam Pharmaceuticals Financial information for Alnylam Pharmaceuticals Alnylam Continues To Deliver, But An U...
ALNY - Alnylam wins FDA panel backing additional Onpattro indications

2023-09-13 17:00:37 ET More on Alnylam Pharmaceuticals Alnylam Continues To Deliver, But An Upcoming FDA Meeting Could Create Some Volatility Alnylam: Unlimited Promise Or Unlimited Losses? Alnylam succeeds in Phase 2 trial for blood pressure drug Seeking Alp...

ALNY - Alnylam Announces Positive Outcome of FDA Advisory Committee Meeting on Patisiran for the Treatment of the Cardiomyopathy of ATTR Amyloidosis

– Cardiovascular and Renal Drugs Advisory Committee Voted 9:3 That the Benefits of Patisiran Outweigh its Risks for the Treatment of the Cardiomyopathy of ATTR Amyloidosis – – Prescription Drug User Fee Act Target Action Date is October 8, 2023 – Al...

ALNY - Alnylam stock trading halted as FDA AdCom meets on amyloidosis drug

2023-09-13 08:25:41 ET More on Alnylam Seeking Alpha’s Quant Rating on Alnylam Pharmaceuticals Historical earnings data for Alnylam Pharmaceuticals Financial information for Alnylam Pharmaceuticals Alnylam Continues To Deliver, But An Upcoming FDA Meet...
Previous 10 Next 10